173 related articles for article (PubMed ID: 36531020)
1. Pyroptosis-related lncRNAs: A novel prognosis signature of colorectal cancer.
Cai X; Liang X; Wang K; Liu Y; Hao M; Li H; Dai X; Ding L
Front Oncol; 2022; 12():983895. PubMed ID: 36531020
[TBL] [Abstract][Full Text] [Related]
2. An innovative pyroptosis-related long-noncoding-RNA signature predicts the prognosis of gastric cancer
Xiong S; Jin L; Zeng C; Ma H; Xie L; Liu S
Pathol Oncol Res; 2022; 28():1610712. PubMed ID: 36567977
[No Abstract] [Full Text] [Related]
3. Clinical Significance and Immune Landscape of a Pyroptosis-Derived LncRNA Signature for Glioblastoma.
Xing Z; Liu Z; Fu X; Zhou S; Liu L; Dang Q; Guo C; Ge X; Lu T; Zheng Y; Dai L; Han X; Wang X
Front Cell Dev Biol; 2022; 10():805291. PubMed ID: 35223836
[No Abstract] [Full Text] [Related]
4. Construction of a pyroptosis-related lncRNAs signature for predicting prognosis and immunotherapy response in glioma.
Huang Q; Yan J; Jiang Q; Guo F; Mo L; Deng T
Medicine (Baltimore); 2023 Feb; 102(6):e32793. PubMed ID: 36820554
[TBL] [Abstract][Full Text] [Related]
5. Construction and Validation of a Novel Pyroptosis-Related Four-lncRNA Prognostic Signature Related to Gastric Cancer and Immune Infiltration.
Wang Z; Cao L; Zhou S; Lyu J; Gao Y; Yang R
Front Immunol; 2022; 13():854785. PubMed ID: 35392086
[TBL] [Abstract][Full Text] [Related]
6. Pyroptosis-Related lncRNA Prognostic Model for Renal Cancer Contributes to Immunodiagnosis and Immunotherapy.
Zhou X; Yao L; Zhou X; Cong R; Luan J; Wei X; Zhang X; Song N
Front Oncol; 2022; 12():837155. PubMed ID: 35860590
[TBL] [Abstract][Full Text] [Related]
7. Characterization of sialylation-related long noncoding RNAs to develop a novel signature for predicting prognosis, immune landscape, and chemotherapy response in colorectal cancer.
Zhou M; Lv S; Hou Y; Zhang R; Wang W; Yan Z; Li T; Gan W; Zeng Z; Zhang F; Yang M
Front Immunol; 2022; 13():994874. PubMed ID: 36330513
[TBL] [Abstract][Full Text] [Related]
8. Development of a novel hypoxia-immune-related LncRNA risk signature for predicting the prognosis and immunotherapy response of colorectal cancer.
Luan L; Dai Y; Shen T; Yang C; Chen Z; Liu S; Jia J; Li Z; Fang S; Qiu H; Cheng X; Yang Z
Front Immunol; 2022; 13():951455. PubMed ID: 36189298
[TBL] [Abstract][Full Text] [Related]
9. Identification and Validation of a Three Pyroptosis-Related lncRNA Signature for Prognosis Prediction in Lung Adenocarcinoma.
Liu J; Liu Q; Shen H; Liu Y; Wang Y; Wang G; Du J
Front Genet; 2022; 13():838624. PubMed ID: 35928454
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive Analysis of the Correlation Between Pyroptosis-Related LncRNAs and Tumor Microenvironment, Prognosis, and Immune Infiltration in Hepatocellular Carcinoma.
Qu G; Wang D; Xu W; Guo W
Front Genet; 2022; 13():867627. PubMed ID: 35559014
[No Abstract] [Full Text] [Related]
11. A Novel Pyroptosis-Associated Long Noncoding RNA Signature to Predict the Prognosis of Patients with Colorectal Cancer.
Chen S; Zhu J; Zhi X
Int J Gen Med; 2021; 14():6111-6123. PubMed ID: 34611426
[TBL] [Abstract][Full Text] [Related]
12. Derivation, Comprehensive Analysis, and Assay Validation of a Pyroptosis-Related lncRNA Prognostic Signature in Patients With Ovarian Cancer.
Cao X; Zhang Q; Zhu Y; Huo X; Bao J; Su M
Front Oncol; 2022; 12():780950. PubMed ID: 35280739
[TBL] [Abstract][Full Text] [Related]
13. Cross-Talk Between m
Song W; Ren J; Xiang R; Yuan W; Fu T
Front Immunol; 2022; 13():740960. PubMed ID: 35350786
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive analysis of cuproptosis-related lncRNAs to predict prognosis and immune infiltration characteristics in colorectal cancer.
Zhu Z; Zhao Q; Li S; Weng J; Guo T; Zhu C; Xu Y
Front Genet; 2022; 13():984743. PubMed ID: 36467996
[No Abstract] [Full Text] [Related]
15. Exploring the role of pyroptosis in shaping the tumor microenvironment of colorectal cancer by bulk and single-cell RNA sequencing.
Ding C; Yang X; Li S; Zhang E; Fan X; Huang L; He Z; Sun J; Ma J; Zang L; Zheng M
Cancer Cell Int; 2023 May; 23(1):95. PubMed ID: 37198617
[TBL] [Abstract][Full Text] [Related]
16. Integrated single-cell and bulk RNA sequencing analysis identifies a cancer associated fibroblast-related signature for predicting prognosis and therapeutic responses in colorectal cancer.
Zheng H; Liu H; Ge Y; Wang X
Cancer Cell Int; 2021 Oct; 21(1):552. PubMed ID: 34670584
[TBL] [Abstract][Full Text] [Related]
17. Cancer-associated fibroblast-related gene signatures predict survival and drug response in patients with colorectal cancer.
Zhang L; Xu C; Wang SH; Ge QW; Wang XW; Xiao P; Yao QH
Front Genet; 2022; 13():1054152. PubMed ID: 36506313
[No Abstract] [Full Text] [Related]
18. N6-Methyladenosine-Related lncRNA Signature Predicts the Overall Survival of Colorectal Cancer Patients.
Song W; Ren J; Yuan W; Xiang R; Ge Y; Fu T
Genes (Basel); 2021 Aug; 12(9):. PubMed ID: 34573357
[TBL] [Abstract][Full Text] [Related]
19. Identification of pyroptosis-related lncRNA signature and AC005253.1 as a pyroptosis-related oncogene in prostate cancer.
Yu J; Tang R; Li J
Front Oncol; 2022; 12():991165. PubMed ID: 36248980
[TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA profile study identifies a metabolism-related signature for colorectal cancer.
Lu Y; Wang W; Liu Z; Ma J; Zhou X; Fu W
Mol Med; 2021 Aug; 27(1):83. PubMed ID: 34344319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]